Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT00306384 · COMPLETED

Trial details

NCT number: NCT00306384
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2006-03-01
Primary completion: 2011-11-01
Enrollment: 3323

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.